+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Intravenous Solutions Market Size, Share & Trends Analysis Report by Product, Animal Type (Companion Animals, Production Animals), Indication, End-use, and Region with Growth Forecasts, 2025-2030- Product Image
Veterinary Intravenous Solutions Market Size, Share & Trends Analysis Report by Product, Animal Type (Companion Animals, Production Animals), Indication, End-use, and Region with Growth Forecasts, 2025-2030- Product Image
New

Veterinary Intravenous Solutions Market Size, Share & Trends Analysis Report by Product, Animal Type (Companion Animals, Production Animals), Indication, End-use, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 150 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 5853841
Description Jump to:
The Veterinary Intravenous Solutions Market was valued at USD 1.45 billion in 2024, and is projected to reach USD 2.07 billion by 2030, rising at a CAGR of 6.21%. The growth is driven by increasing awareness of animal welfare, advancements in veterinary healthcare, increasing pet ownership, and the increasing prevalence of illnesses such as anthrax, pancreatitis, and mouth disease. The advancements in veterinary medicine have expanded the range of treatment options available for animals. Veterinary clinics and hospitals are equipped with advanced diagnostic and treatment facilities, including intravenous fluid administration systems, which contribute to the growth of the market.

The development of advanced IV fluid delivery systems designed specifically for veterinary use has made the administration process more efficient, accurate, and safe. These technological advancements, such as specialized infusion pumps and fluid monitoring systems, have positively impacted the veterinary intravenous solutions industry by enhancing patient care and reducing the risk of complications. Rising disposable income levels in many regions have led to increased spending on pet healthcare. Pet owners are more willing to invest in high-quality veterinary care, including intravenous fluid therapy, which contributes to the growth of the market.

The post-COVID-19 impact on the veterinary intravenous solutions industry is still unfolding as the global situation continues to evolve. The COVID-19 pandemic recovery has led to an increased demand for veterinary intravenous solutions as part of the standard care provided to animals during surgeries, treatments, and critical care situations. The economic impact of the pandemic affected many individuals and businesses, including pet owners and veterinary clinics. Financial constraints may have influenced the decision-making process for pet owners, potentially leading to a decrease in non-essential veterinary procedures and treatments, including the use of IV fluids.

Moreover, the adoption of veterinary intravenous (IV) fluid solutions in North America is relatively high due to various factors such as veterinary education programs in North America emphasizing the importance of IV fluid therapy and its appropriate use in different clinical situations. Veterinarians and veterinary technicians receive extensive training in the administration, monitoring, and management of IV fluids, ensuring their competent use in practice. Furthermore, veterinary professionals in North America strive to provide high-quality care for animals. IV fluid therapy is a crucial component of comprehensive veterinary treatment, and its adoption is driven by the commitment to optimize patient care and support the recovery and well-being of animals.

Veterinary Intravenous Solutions Market Report Highlights

  • Based on product, the isotonic crystalloids segment dominated the market with a share of over 42.00% in 2024. To restore and maintain hydration and electrolyte balance in animals, fluid therapy in veterinary medicine frequently uses isotonic crystalloid solutions
  • Based on animal type, the companion animals segment dominated the market in 2024. Many homes regularly keep companion animals as pets, especially dogs and cats. Pet ownership leads to a large demand for veterinary intravenous solutions, as these animals frequently require intravenous therapy for a variety of health issues, surgeries, or critical care situations
  • Based on indication, the diabetic ketoacidosis segment dominated the market for veterinary intravenous (IV) solutions with a revenue share of over 28.0% in 2024.
  • Based on end-use, the veterinary hospital segment accounted for the highest share in the market 2024, as more people are taking their pets to veterinarian facilities for care. IV hydration therapy is frequently used in veterinary hospitals as a crucial part of patient care
  • North America held the highest revenue share of over 38.09% of the market in 2024. In North America, there is a high rate of pet ownership, with many homes keeping companion animals like dogs, cats, and small mammals

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Veterinary Intravenous (IV) Solutions Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Prevalence of Animal Disease and Dehydration
3.2.1.2. Rising Uptake of Pet Insurance
3.2.1.3. Increase in Pet Ownership and Pet Expenditure
3.2.2. Market Restraint Analysis
3.2.2.1. Risk of Infection and Complications
3.2.2.2. Preference of Oral Alternatives
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Veterinary Intravenous (IV) Solutions Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.3. Regulatory Framework
3.3.4. Pricing Analysis
3.3.5. Manufacturing, Demand, and Supply Chain Analysis
3.3.6. Estimated Animal Population by key countries, key species, 2024
Chapter 4. Veterinary Intravenous (IV) Solutions Market: Animal Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Veterinary Intravenous (IV) Solutions Market: Animal Type Movement Analysis
4.3. Veterinary Intravenous (IV) Solutions Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
4.4. Production Animals
4.4.1. Production Animals Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Companion Animals
4.5.1. Companion Animals Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Veterinary Intravenous (IV) Solutions Market: By Product Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Veterinary Intravenous (IV) Solutions Market: By Product Movement Analysis
5.3. Veterinary Intravenous (IV) Solutions Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
5.3.1. Isotonic crystalloids
5.3.1.1. Isotonic crystalloids Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.2. Synthetic colloids
5.3.2.1. Synthetic Colloids Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.3. Blood products
5.3.3.1. Blood Products Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.4. Dextrose solution
5.3.4.1. Dextrose Solution Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.5. Parenteral nutrition
5.3.5.1. Parenteral Nutrition Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Veterinary Intravenous (IV) Solutions Market: By Indication Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Veterinary Intravenous (IV) Solutions Market: By Indication Movement Analysis
6.3. Veterinary Intravenous (IV) Solutions Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
6.3.1. Diabetic Ketoacidosis
6.3.1.1. Diabetic Ketoacidosis Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.3.2. Pancreatitis
6.3.2.1. Pancreatitis Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.3.3. Anthrax
6.3.3.1. Anthrax Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.3.4. Chronic Kidney Disease
6.3.4.1. Chronic Kidney Disease Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.3.5. Others
6.3.5.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Veterinary Intravenous (IV) Solutions Market: By End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Veterinary Intravenous (IV) Solutions Market: By End Use Movement Analysis
7.3. Veterinary Intravenous (IV) Solutions Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.3.1. Veterinary Hospitals
7.3.1.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.3.2. Research Institutes
7.3.2.1. Research Institutes Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.3.3. Others
7.3.3.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. Veterinary Intravenous (IV) Solutions Market: Regional Estimates & Trend Analysis
8.1. Regional Dashboard
8.2. Veterinary Intravenous (IV) Solutions Market Share, By Region, 2024 & 2030 (USD Million)
8.3. Regional Outlook
8.4. North America
8.4.1. North America Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. U.S. Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Canada Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Mexico Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.5. Europe
8.5.1. Europe Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. UK Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Germany Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. France Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Italy Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Spain Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.5.7. Denmark
8.5.7.1. Key Country Dynamics
8.5.7.2. Denmark Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.5.8. Sweden
8.5.8.1. Key Country Dynamics
8.5.8.2. Sweden Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.5.9. Norway
8.5.9.1. Key Country Dynamics
8.5.9.2. Norway Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Japan Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. China Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. India Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.6.5. Australia
8.6.5.1. Key Country Dynamics
8.6.5.2. Australia Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.6.6. South Korea
8.6.6.1. Key Country Dynamics
8.6.6.2. South Korea Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key Country Dynamics
8.6.7.2. Thailand Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.7. Latin America
8.7.1. Latin America Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Brazil Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Argentina Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.8. Middle East & Africa
8.8.1. Middle East & Africa Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. South Africa Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Saudi Arabia Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. UAE Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Kuwait Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Company Market Position Analysis/ Heap Map Analysis
9.3. Company Profiles
9.3.1. Merck & Co., Inc
9.3.1.1. Participant’s Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Dechra.
9.3.2.1. Participant’s Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Animalcare Limited
9.3.3.1. Participant’s Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Elanco Animal Health Incorporated
9.3.4.1. Participant’s Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Zoetis
9.3.5.1. Participant’s Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Scopio B. Braun Vet Care (B Braun SE)
9.3.6.1. Participant’s Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.4. Strategy Mapping
9.4.1. Mergers & Acquisitions
9.4.2. Partnerships & Collaborations
9.4.3. Product launch
9.4.4. Others
9.5. List of other key players
List of Tables
Table 1 List of secondary sources
Table 2 Veterinary Intravenous (IV) Solutions Market, by region, 2018-2030 (USD Million)
Table 3 Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 4 Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 5 Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 6 Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 7 North America Veterinary Intravenous (IV) Solutions Market, by country, 2018-2030 (USD Million)
Table 8 North America Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 9 North America Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 10 North America Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 11 North America Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 12 U.S. Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 13 U.S. Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 14 U.S. Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 15 U.S. Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 16 Canada Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 17 Canada Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 18 Canada Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 19 Canada Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 20 Mexico Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 21 Mexico Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 22 Mexico Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 23 Mexico Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 24 Europe Veterinary Intravenous (IV) Solutions Market, by country, 2018-2030 (USD Million)
Table 25 Europe Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 26 Europe Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 27 Europe Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 28 Europe Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 29 Germany Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 30 Germany Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 31 Germany Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 32 Germany Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 33 UK Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 34 UK Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 35 UK Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 36 UK Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 37 France Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 38 France Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 39 France Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 40 France Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 41 Italy Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 42 Italy Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 43 Italy Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 44 Italy Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 45 Spain Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 46 Spain Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 47 Spain Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 48 Spain Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 49 Denmark Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 50 Denmark Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 51 Denmark Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 52 Denmark Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 53 Sweden Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 54 Sweden Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 55 Sweden Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 56 Sweden Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 57 Norway Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 58 Norway Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 59 Norway Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 60 Norway Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 61 Asia Pacific Veterinary Intravenous (IV) Solutions Market, by country, 2018-2030 (USD Million)
Table 62 Asia Pacific Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 63 Asia Pacific Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 64 Asia Pacific Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 65 Asia Pacific Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 66 China Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 67 China Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 68 China Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 69 China Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 70 Japan Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 71 Japan Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 72 Japan Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 73 Japan Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 74 India Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 75 India Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 76 India Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 77 India Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 78 South Korea Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 79 South Korea Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 80 South Korea Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 81 South Korea Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 82 Australia Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 83 Australia Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 84 Australia Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 85 Australia Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 86 Thailand Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 87 Thailand Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 88 Thailand Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 89 Thailand Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 90 Latin America Veterinary Intravenous (IV) Solutions Market, by country, 2018-2030 (USD Million)
Table 91 Latin America Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 92 Latin America Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 93 Latin America Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 94 Latin America Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 95 Brazil Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 96 Brazil Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 97 Brazil Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 98 Brazil Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 99 Argentina Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 100 Argentina Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 101 Argentina Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 102 Argentina Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 103 MEA Veterinary Intravenous (IV) Solutions Market, by country, 2018-2030 (USD Million)
Table 104 MEA Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 105 MEA Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 106 MEA Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 107 MEA Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 108 South Africa Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 109 South Africa Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 110 South Africa Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 111 South Africa Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 112 Saudi Arabia Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 113 Saudi Arabia Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 114 Saudi Arabia Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 115 Saudi Arabia Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 116 UAE Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 117 UAE Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 118 UAE Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 119 UAE Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 120 Kuwait Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018-2030 (USD Million)
Table 121 Kuwait Veterinary Intravenous (IV) Solutions Market, by Indication, 2018-2030 (USD Million)
Table 122 Kuwait Veterinary Intravenous (IV) Solutions Market, by Product, 2018-2030 (USD Million)
Table 123 Kuwait Veterinary Intravenous (IV) Solutions Market, by End use, 2018-2030 (USD Million)
Table 124 Company Overview
Table 125 Product Benchmarking
Table 126 Financial Performance
Table 127 Strategic Initiatives
List of Figures
Figure 1 Market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value chain-based sizing & forecasting
Figure 7 QFD modelling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Veterinary Intravenous (IV) Solutions Market revenue, 2018-2030 (USD Million)
Figure 10 Veterinary Intravenous (IV) Solutions Market snapshot
Figure 11 Veterinary Intravenous (IV) Solutions Market driver impact
Figure 12 Veterinary Intravenous (IV) Solutions Market restraint impact
Figure 13 Veterinary Intravenous (IV) Solutions animal type key takeaways (USD Million)
Figure 14 Veterinary Intravenous (IV) Solutions Market: animal Type movement analysis
Figure 15 Companion animals market, 2018-2030 (USD Million)
Figure 16 Production animals market, 2018-2030 (USD Million)
Figure 17 Veterinary Intravenous (IV) Solutions Market Product key takeaways (USD Million)
Figure 18 Veterinary Intravenous (IV) Solutions Market: product movement analysis
Figure 19 Isotonic crystalloids market, 2018-2030 (USD Million)
Figure 20 Synthetic colloids market, 2018-2030 (USD Million)
Figure 21 Blood products market, 2018-2030 (USD Million)
Figure 22 Dextrose Solution market, 2018-2030 (USD Million)
Figure 23 Parenteral nutrition market, 2018-2030 (USD Million)
Figure 24 Veterinary Intravenous (IV) Solutions Market Indication key takeaways (USD Million)
Figure 25 Veterinary Intravenous (IV) Solutions Market: Indication movement analysis
Figure 26 Diabetic Ketoacidosis market, 2018-2030 (USD Million)
Figure 27 Pancreatitis market, 2018-2030 (USD Million)
Figure 28 Anthrax market, 2018-2030 (USD Million)
Figure 29 Chronic Kidney Disease market, 2018-2030 (USD Million)
Figure 30 Others market, 2018-2030 (USD Million)
Figure 31 Veterinary Intravenous (IV) Solutions Market by End Use key takeaways (USD Million)
Figure 32 Veterinary Intravenous (IV) Solutions Market: by End Use movement analysis
Figure 33 Veterinary Research Institutes market, 2018-2030 (USD Million)
Figure 34 Veterinary Hospitals market, 2018-2030 (USD Million)
Figure 35 Research Institutes market, 2018-2030 (USD Million)
Figure 36 Others market, 2018-2030 (USD Million)
Figure 37 Regional market place: Key takeaways
Figure 38 Regional outlook, 2024 & 2030
Figure 39 North America Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 40 U.S. Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 41 Canada Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 42 Mexico Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 43 Europe Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 44 UK Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 45 Germany Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 46 France Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 47 Italy Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 48 Spain Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 49 Denmark Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 50 Sweden Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 51 Norway Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 52 Asia Pacific Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 53 Japan Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 54 China Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 55 India Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 56 Australia Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 57 South Korea Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 58 Thailand Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 59 Latin America Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 60 Brazil Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 61 Argentina Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 62 MEA Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 63 South Africa Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 64 Saudi Arabia Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 65 UAE Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 66 Kuwait Veterinary Intravenous (IV) Solutions Market, 2018-2030 (USD Million)
Figure 67 Market participant categorization

Companies Mentioned

The major companies featured in this Veterinary Intravenous Solutions market report include:
  • Merck & Co., Inc (Animal Health
  • Dechra
  • Animalcare Limited
  • B. Braun Vet Care (B Braun SE)
  • Elanco Animal Health Incorporated (Animal Health)
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages150
PublishedMay 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.45 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.07 Billion
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned7

Related Topics

Related Reports

Veterinary Intravenous (IV) Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Veterinary Intravenous (IV) Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Veterinary Intravenous (IV) Solutions Market Report 2025 - Product Image

Veterinary Intravenous (IV) Solutions Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Veterinary Biomarkers Market Size, Share & Trends Analysis Report by Animal Type (Companion Animals, Production Animals), Product (Biomarker, Kits & Reagents), Application, Disease Type, and Region with Growth Forecasts, 2025-2030 - Product Image

Veterinary Biomarkers Market Size, Share & Trends Analysis Report by Animal Type (Companion Animals, Production Animals), Product (Biomarker, Kits & Reagents), Application, Disease Type, and Region with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Veterinary Pain Management Market Size, Share & Trends Analysis Report By Indication (Osteoarthritis, Postoperative Pain, Others), By Product, By Route of Administration, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Veterinary Pain Management Market Size, Share & Trends Analysis Report By Indication (Osteoarthritis, Postoperative Pain, Others), By Product, By Route of Administration, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Cat Medicines Market by Therapeutic Area, Product Type, Route of Administration, End User - Global Forecast to 2030 - Product Image

Cat Medicines Market by Therapeutic Area, Product Type, Route of Administration, End User - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.